| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 217459-10-4 | [(1,2,3,4,5-eta)-1,2,3,4,5-Pentamethyl-2,4-cyclopentadien-1-yl][(4a,5,6,7,7a-eta)-(7aR)-4-(1-pyrrolidinyl)-4aH-cyclopenta[b]pyridin-4a-yl]iron | C22H28FeN2 |
| 217466-37-0 | 1-Hydroxy-2-oxopomolic acid | C30H46O6 |
| 217479-60-2 | 2,4,6-Trichlorobenzenemethanol | C7H5Cl3O |
| 217488-65-8 | Monuron D6 | C9H11ClN2O |
| 217500-96-4 | Tulathromycin A | C41H79N3O12 |
| 217501-55-8 | Styrene-alpha,2,3,4,5,6-d6 | C8H2D6 |
| 217636-47-0 | Fenofibrate EP Impurity C | C17H15ClO3 |
| 217636-48-1 | 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid 1,1-dimethyl-2-(1-methylethoxy)-2-oxoethyl ester | C24H27ClO6 |
| 217645-70-0 | (2R)-1-[[[4-Chloro-2-(ureido)phenoxy]methyl]carbonyl]-2-methyl-4-(4-fluorobenzyl)piperazine | C21H24ClFN4O3 |
| 217650-27-6 | 4-Cadinen-7-ol | C15H26O |
| 217782-56-4 | GenBank AI175418 | |
| 217797-14-3 | Paroxetine mesylate | C19H20FNO3.CH4O3S |
| 217806-26-3 | 3-Boc-Aminoazetidine hydrochloride | C8H16N2O2.HCl |
| 217810-46-3 | Japonica acid | C18H26O4 |
| 217811-85-3 | Methyl 2-bromo-4-methoxy-3-pyridinecarboxylate | C8H8BrNO3 |
| 217817-09-9 | Curcolonol | C15H20O4 |
| 217942-71-7 | 3-(2-Chlorophenyl)-6-fluoro-2-[[(2-fluorophenyl)amino]methyl]-4(3H)-quinazolinone | C21H14ClF2N3O |
| 217958-64-0 | Siloxanes and Silicones, di-Me, 3-hydroxypropyl group-terminated, diethers with polyethylene glycol monoacrylate, polymers with acrylic acid and polyethylene glycol monoallyl ether | |
| 217959-45-0 | 5-Trifluoromethyl-3-hydroxythiophene | C5H3F3OS |
| 217973-03-0 | 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid trisodium salt | C14H23N4O6.Na3 |
| 217973-05-2 | 3-Methyl-[1,4]diazepan-2-one | C6H12N2O |
| 218131-11-4 | Silaplane FM-DA 26 | |
| 218136-59-5 | SC 26196 | C27H29N5 |
| 218151-47-4 | (1S,2S)-2,3-Dihydro-1H-indene-1,2-diamine | C9H12N2 |
| 218151-48-5 | (1R,2R)-2,3-Dihydro-1H-indene-1,2-diamine | C9H12N2 |
| 218151-56-5 | (1S,2R)-2,3-Dihydro-1H-indene-1,2-diamine | C9H12N2 |
| 218151-57-6 | (1R,2S)-2,3-Dihydro-1H-indene-1,2-diamine | C9H12N2 |
| 218151-78-1 | 1,2-Dimethyl-3-propylimidazolium iodide | C8H15N2.I |
| 218156-96-8 | N-[2-(1-Piperidinyl)-5-(trifluoromethyl)phenyl]-4-pyridinecarboxamide | C18H18F3N3O |
| 218168-58-2 | N-(4-Cyanophenyl)glycine ethyl ester | C11H12N2O2 |
| 218269-34-2 | 3A,3B,3C,3D,6E,6F,6G-Heptakis-O-(carboxymethyl)-beta-cyclodextrin | C56H84O49 |
| 218278-58-1 | 1-Boc-4-Fmoc-2-piperazinecarboxylic acid | C25H28N2O6 |
| 218278-62-7 | (S)-3-Amino-5-phenylpentanoic acid hydrochloride | C11H15NO2.HCl |
| 218290-24-5 | trans-1,2-Bis(2-pyridinecarboxamido)cyclohexane | C18H20N4O2 |
| 218290-59-6 | Macrocarpal K | C28H40O6 |
| 218300-22-2 | 4-[3-(3-Methyl-2(3H)-benzothiazolylidene)-1-propen-1-yl]-1-octylquinolinium 1,1,1-trifluoromethanesulfonate | C28H33N2S.CF3O3S |
| 218301-22-5 | 3-Cyano-4-fluorobenzaldehyde | C8H4FNO |
| 218301-87-2 | 4-N-Boc-amino-3-fluorophenylboronic acid | C11H15BFNO4 |
| 218433-98-8 | 1-[N2-[5-[(3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-L-glutamine]-luteinizing hormone-releasing factor (swine) | C65H92N20O15S |
| 218441-99-7 | Brain-derived neurotrophic factor (human) | |
| 218457-99-9 | tert-Butyl 2-butynoate | C8H12O2 |
| 218594-01-5 | (S)-N-Boc-3-morpholinecarbaldehyde | C10H17NO4 |
| 218594-02-6 | 4-Boc-2-morpholinecarbaldehyde | C10H17NO4 |
| 218594-15-1 | tert-Butyl (6-bromopyridin-3-yl)carbamate | C10H13BrN2O2 |
| 218594-79-7 | (S)-Morpholin-3-ylmethanol hydrochloride | C5H11NO2.HCl |
| 218594-80-0 | (3R)-3-(Fluoromethyl)-4-(phenylmethyl)morpholine | C12H16FNO |
| 218594-84-4 | (3S)-3-Morpholinecarboxylic acid ethyl ester hydrochloride | C7H13NO3.HCl |
| 218595-25-6 | (S)-3-(Methoxymethyl)morpholine | C6H13NO2 |
| 218600-44-3 | 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic acid | C31H41NO4 |
| 218600-48-7 | Oleana-2,12-dieno[2,3-d]isoxazol-28-oic acid | C31H45NO3 |